These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 29760258)

  • 41. Antipsychotic treatment of psychosis and agitation in the elderly.
    Daniel DG
    J Clin Psychiatry; 2000; 61 Suppl 14():49-52. PubMed ID: 11154017
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Treatment of the agitated demented elderly patient.
    Salzman C
    Hosp Community Psychiatry; 1988 Nov; 39(11):1143-4. PubMed ID: 2906318
    [No Abstract]   [Full Text] [Related]  

  • 43. Risperidone for the treatment of behavioral disturbances in dementia: a case series.
    Herrmann N; Rivard MF; Flynn M; Ward C; Rabheru K; Campbell B
    J Neuropsychiatry Clin Neurosci; 1998; 10(2):220-3. PubMed ID: 9608413
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Antipsychotics can be withdrawn from many older people with dementia, though caution is needed for people with more severe neuropsychiatric symptoms.
    Gill SS; Seitz DP
    Evid Based Ment Health; 2013 Aug; 16(3):81. PubMed ID: 23766414
    [No Abstract]   [Full Text] [Related]  

  • 45. The comparative efficacy of intramuscular antipsychotics for the management of acute agitation.
    Bosanac P; Hollander Y; Castle D
    Australas Psychiatry; 2013 Dec; 21(6):554-62. PubMed ID: 23996795
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Don't use antipsychotics routinely to treat agitation and aggression in people with dementia.
    Corbett A; Burns A; Ballard C
    BMJ; 2014 Nov; 349():g6420. PubMed ID: 25368388
    [No Abstract]   [Full Text] [Related]  

  • 47. Risks and benefits of antipsychotic drugs in elderly patients with dementia.
    Howland RH
    J Psychosoc Nurs Ment Health Serv; 2008 Nov; 46(11):19-23. PubMed ID: 19051574
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Antipsychotic prescription and mortality in hospitalized older persons.
    Chiesa D; Marengoni A; Nobili A; Tettamanti M; Pasina L; Franchi C; Djade CD; Corrao S; Salerno F; Marcucci M; Romanelli G; Mannucci PM;
    Psychogeriatrics; 2017 Nov; 17(6):397-405. PubMed ID: 28589693
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Clinical perspectives on atypical antipsychotics for treatment of agitation.
    Caine ED
    J Clin Psychiatry; 2006; 67 Suppl 10():22-31. PubMed ID: 16965192
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Report on an open-label prospective study of divalproex sodium for the behavioral and psychological symptoms of dementia as monotherapy and in combination with second-generation antipsychotic medication.
    Forester B; Vanelli M; Hyde J; Perez R; Ahokpossi C; Sribney W; Adkison L
    Am J Geriatr Pharmacother; 2007 Sep; 5(3):209-17. PubMed ID: 17996660
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Reducing Antipsychotics for Dementia Patients in Nursing Homes.
    Garner K; Padala P; Cox-Sullivan S
    J Ark Med Soc; 2015 Jul; 112(1):12-3. PubMed ID: 26164880
    [No Abstract]   [Full Text] [Related]  

  • 52. A randomized, double-blind, crossover comparison of risperidone and haloperidol in Korean dementia patients with behavioral disturbances.
    Suh GH; Son HG; Ju YS; Jcho KH; Yeon BK; Shin YM; Kee BS; Choi SK
    Am J Geriatr Psychiatry; 2004; 12(5):509-16. PubMed ID: 15353389
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pharmacologic treatment of agitation in dementia: a comprehensive review.
    Lantz MS; Marin D
    J Geriatr Psychiatry Neurol; 1996 Jul; 9(3):107-19. PubMed ID: 8873873
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Consequences of antipsychotic medications for the dementia patient.
    Devanand DP; Schultz SK
    Am J Psychiatry; 2011 Aug; 168(8):767-9. PubMed ID: 21813491
    [No Abstract]   [Full Text] [Related]  

  • 55. Agitation in the medically ill elderly.
    Alao AO; Soderberg M; Koss M
    West Afr J Med; 2005; 24(2):171-4. PubMed ID: 16092322
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Benefits and harms of atypical antipsychotics for agitation in adults with dementia.
    Farlow MR; Shamliyan TA
    Eur Neuropsychopharmacol; 2017 Mar; 27(3):217-231. PubMed ID: 28111239
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Duration of risperidone treatment for BPSD.
    Snowdon J; Brodaty H; Ames D; Day S
    Int J Geriatr Psychiatry; 2006 Jul; 21(7):699-701. PubMed ID: 16821255
    [No Abstract]   [Full Text] [Related]  

  • 58. [State of agitation. Diagnostic guidance and procedures in emergencies along with drug dosage recommendations].
    Haffen E; Sechter D
    Rev Prat; 1998 May; 48(10):1123-7. PubMed ID: 9781159
    [No Abstract]   [Full Text] [Related]  

  • 59. Assessment of antipsychotic prescribing in Belgian nursing homes.
    Azermai M; Elseviers M; Petrovic M; van Bortel L; Stichele RV
    Int Psychogeriatr; 2011 Oct; 23(8):1240-8. PubMed ID: 21418723
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Galantamine versus risperidone for agitation in people with dementia: a randomized, twelve-week, single-center study.
    Freund-Levi Y; Bloniecki V; Auestad B; Tysen Bäckström AC; Lärksäter M; Aarsland D
    Dement Geriatr Cogn Disord; 2014; 38(3-4):234-44. PubMed ID: 24969380
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.